5 awards funded:

  • Molecular Genetic and Functional Characterization of Crohn's MSCs Immune Plasticity
    • Jacques Galipeau, MD, Professor, Emory University School of Medicine Hematology & Medical Oncology ($30,000)
    • Greg Gibson, PhD, Professor, Georgia Institute of Technology College of Sciences Biology ($20,000)
  • Immunological and Biomaterial Basis of Hydrogel-Delivered Immunosuppressive Dendritic Cells on Attenuation of Murine Experimental Autoimmune Encephalomyelitis Disease
    • Brian Evavold, PhD, Professor, Emory University School of Medicine Microbiology & Immunology ($25,010)
    • Julia Babensee, PhD, Associate Professor, Georgia Institute of Technology Biomedical Engineering ($24,990)
  • Engineered GIFT4 Fusokine for Hematopoietic Stem Cell lmmunotherapy
    • Jiusheng Deng, PhD, Instructor, Emory University School of Medicine Hematology & Medical Oncology ($30,000)
    • Krishnendu Roy, PhD, Professor, Georgia Institute of Technology Biomedical Engineering ($20,000)
  • Microparticle Delivery of Immunomodulators to Enhance Tuberculosis Vaccines
    • Jyothi Rengarajan, PhD, Assistant Professor, Emory University School of Medicine Infectious Diseases ($32,000)
    • Krishnendu Roy, PhD, Professor, Georgia Institute of Technology Biomedical Engineering ($18,000)
  • lmmunoengineered Micro/Nanobeads to Therapeutically Fix Complement and Mask Incompatible Antigens Prior to Transfusions
    • Sean Stowell, MD, PhD, Assistant Professor, Emory University School of Medicine Pathology & Laboratory Medicine ($25,000)
    • Todd Sulchek, PhD, Associate Professor, Georgia Institute of Technology Mechanical Engineering ($25,000)

Upcoming Events

View All Events

Funding News

Discovery

World-renowned Primatologist Lays Groundwork for Remedying Conflict & Medical Error in the Operating Room with CTSA Pilot Grant

Frans de Waal, PhD, C.H., Candler Professor of Primate Behavior and Psychology at Emory University, and one of the world’s best-known primatologists, was recently awarded an CTSA pilot grant for his work on “Mitigating Conflict...

Discovery

CTSA-supported Models Contribute to the First Possible Drug Treatment for Lymphedema

A recent study led by scientists at the Stanford University School of Medicine uncovered for the first time the molecular mechanism responsible for triggering lymphedema, as well as a drug with the potential for inhibiting that process....